The emerging multidrug-resistant yeast pathogen Candida auris has attracted considerable attention as a source of healthcare-associated infections. We report that this highly virulent yeast has the capacity to form antifungal resistant biofilms sensitive to the disinfectant chlorhexidine in vitro.
Keywords: Candida auris; aggregative phenotypes; antifungal drug resistant; biofilm; candidemia; chlorhexidine; fungi; healthcare–associated infections; killing assay; multidrug resistant; nonaggregative phenotypes; virulent; yeast.